Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-25 @ 2:22 AM
NCT ID:
NCT03235934
Eligibility Criteria:
Inclusion Criteria:
* Adult patients (\> 18 years old) with a new histologically-confirmed diagnosis of glioblastoma who are planned to receive a 6-week course of concurrent radiation and temozolomide
* Has evidence of random glucose of at least 7.8 mmol/L or fasting blood glucose of at least 6.1 mmol/L (meeting criteria for oral diabetic medications)
* Able to provide informed consent
* Able to understand and follow instructions regarding self-administered capillary glucose measurements
Exclusion Criteria:
* Contraindication to MRI with gadolinium
* Taking anti-hyperglycemic medications at the time of study eligibility screen
* Unable to participate in neurocognitive evaluation in English
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03235934
Study Brief:
Protocol Section:
NCT03235934